NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Nova Mentis Life Science Corp (OTCQB: NMLSF)
NMLSF Technical Analysis
5
As on 10th Mar 2025 NMLSF STOCK Price closed @ 0.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.02 & Strong Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NMLSFSTOCK Price
Open | 0.08 | Change | Price | % |
High | 0.10 | 1 Day | 0.09 | 900.00 |
Low | 0.08 | 1 Week | 0.09 | 900.00 |
Close | 0.10 | 1 Month | 0.08 | 513.71 |
Volume | 43535 | 1 Year | 0.06 | 150.00 |
52 Week High 0.05 | 52 Week Low 0.00 |
OTCQB USA Most Active Stocks
FNMA | 4.98 | 9.69% |
BMIX | 0.01 | % |
GCAN | 0.00 | % |
BTCWF | 0.10 | 150.00% |
EMED | 0.00 | % |
FMCC | 4.94 | 12.53% |
INVU | 0.02 | 100.00% |
KGKG | 0.00 | % |
ALPP | 3.56 | 0.00% |
ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
NMLSF Daily Charts |
NMLSF Intraday Charts |
Whats New @ Bazaartrend |
NMLSF Free Analysis |
|
NMLSF Important Levels Intraday
RESISTANCE | 0.14 |
RESISTANCE | 0.13 |
RESISTANCE | 0.12 |
RESISTANCE | 0.11 |
SUPPORT | 0.09 |
SUPPORT | 0.08 |
SUPPORT | 0.07 |
SUPPORT | 0.06 |
NMLSF Forecast March 2025
4th UP Forecast | 0.14 |
3rd UP Forecast | 0.13 |
2nd UP Forecast | 0.12 |
1st UP Forecast | 0.11 |
1st DOWN Forecast | 0.09 |
2nd DOWN Forecast | 0.08 |
3rd DOWN Forecast | 0.07 |
4th DOWN Forecast | 0.06 |
NMLSF Weekly Forecast
4th UP Forecast | 0.12 |
3rd UP Forecast | 0.11 |
2nd UP Forecast | 0.11 |
1st UP Forecast | 0.11 |
1st DOWN Forecast | 0.09 |
2nd DOWN Forecast | 0.09 |
3rd DOWN Forecast | 0.09 |
4th DOWN Forecast | 0.08 |
NMLSF Forecast2025
4th UP Forecast | 0.29 |
3rd UP Forecast | 0.23 |
2nd UP Forecast | 0.19 |
1st UP Forecast | 0.15 |
1st DOWN Forecast | 0.05 |
2nd DOWN Forecast | 0.01 |
3rd DOWN Forecast | -0.03 |
4th DOWN Forecast | -0.09 |
Nova Mentis Life Science Corp ( OTCQB USA Symbol : NMLSF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NMLSF Other Details
Segment | EQ | |
Market Capital | 10430028.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
NMLSF Address
![]() |
NMLSF Latest News
NMLSF Business Profile
Nova Mentis Life Science Corp., through its subsidiaries, engages in the research and development of medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder in Canada. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes; and development of cannabis products. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Address: 700-838 West Hasting Street, Vancouver, BC, Canada, V6C 0A6
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service